放疗、介入化疗同期应用治疗晚期宫颈癌

来源 :中国肿瘤临床与康复 | 被引量 : 0次 | 上传用户:qiaomy
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的比较放疗、介入化疗同期应用与单纯常规放射治疗晚期宫颈鳞癌的疗效。方法子宫颈鳞癌常规外放疗10~20Gy时,辅以介入化疗的晚期宫颈癌12例与同期接受单纯常规放疗的晚期宫颈癌20例做比较。比较两组病例肿瘤缩小情况、毒性反应、3年复发及死亡率。结果治疗组(放疗、介入化疗同期应用组)肿瘤缩小明显优于对照组(单纯常规放疗组),毒性反应两组病人均能耐受,平均治疗天数治疗组为69天,对照组为67天,无明显差别。结论放疗同期介入化疗较单纯常规放疗者肿瘤缩小明显,Ⅲb期病人治疗组3年生存率高于对照组,治疗组副反应可以耐受,平均治疗天数两组无明显差别。 Objective To compare the curative effects of concurrent radiotherapy, simultaneous interventional chemotherapy and conventional radiotherapy for advanced cervical squamous cell carcinoma. Methods Conventional external radiotherapy of cervical squamous carcinoma 10 ~ 20Gy, adjuvant chemotherapy with advanced cervical cancer in 12 cases compared with the same period received conventional radiotherapy for advanced cervical cancer in 20 cases were compared. Tumor shrinkage, toxicity, 3-year relapse and mortality were compared between the two groups. Results Compared with the control group (conventional radiotherapy group), tumor shrinkage in the treatment group (radiotherapy and interventional chemotherapy group) was significantly better than that in the control group. The patients in the two groups were able to tolerate the treatment for an average of 69 days in the treatment group and 67 days in the control group , No significant difference. Conclusions Compared with conventional radiotherapy, the 3-year survival rate of Ⅲb patients is higher than that of control group. The side effects of the treatment group can be tolerated, and the average treatment days have no significant difference between the two groups.
其他文献
2016年以来,以移动互联app为载体的共享单车火爆发展。目前有近30个共享单车品牌,其中摩拜在全国超过30个城市运营,投放超过300万辆单车,注册用户已达数千万,ofo注册用户达25
自然生命或生物系统的诸多技能是生物个体在发育成长过程中渐进地形成和发展起来的。技能的形成和发展过程是生物系统的认知过程,是自然生命认知能力的体现。理解和模拟自然
本文系美籍中国音乐学者赵如兰为本刊所撰的特稿,文中提供了不少有关赵元任先生音乐生活的第一手资料。
针对脑机接口(BCI)中的共享控制问题,提出一种BCI系统的Petri网建模方法.首先,将共享控制策略与BCI系统的内外部信息相结合,构建运动想象BCI系统的Petri网模型,描述系统的运
<正> 随着新技术、新材料的发展,电扇在保持其基本功能的同时,也获得相应发展,尤其是微电子技术使得电扇性能更为优异,水平提高一大步。近年来,随着空调器的不断普及,电风扇